Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Bluejay Diagnostics, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/24/2023 |
4
| Dey Svetlana (Director) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 10,000 shares
@ $0.44, valued at
$4.4k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/07/2022 |
4
| Fisher Kenneth R (CFO) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Bought 20,000 shares
@ $1.03, valued at
$20.6k
|
|
04/27/2022 |
4
| Fisher Kenneth R (CFO) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Bought 20,000 shares
@ $0.99, valued at
$19.8k
|
|
03/28/2022 |
4
| Fisher Kenneth R (CFO) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 65,000 options to buy
@ $1.31, valued at
$85.2k
|
|
03/23/2022 |
4
| Gemignani Gary G (Director) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 2,500 options to buy
@ $1.26, valued at
$3.2k
|
|
03/23/2022 |
4
| CHASE DONALD R (Director) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 2,500 options to buy
@ $1.26, valued at
$3.2k
|
|
03/23/2022 |
4
| ZEIDMAN FRED S (Director) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 2,500 options to buy
@ $1.26, valued at
$3.2k
|
|
03/23/2022 |
4
| Wurth Douglas Clark (10% Owner) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 2,500 options to buy
@ $1.26, valued at
$3.2k
|
|
03/23/2022 |
4
| Dey Svetlana (10% Owner) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 2,500 options to buy
@ $1.26, valued at
$3.2k
|
|
03/21/2022 |
4
| Kinder Gordon Winston (CFO) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Bought 2,500 shares
@ $1.159, valued at
$2.9k
|
|
03/21/2022 |
4
| Dey Svetlana (10% Owner) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Bought 10,000 shares
@ $1.183, valued at
$11.8k
|
|
03/18/2022 |
4
| Wurth Douglas Clark (10% Owner) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Bought 40,000 shares
@ $1.178, valued at
$47.1k
|
|
03/17/2022 |
4
| Wurth Douglas Clark (10% Owner) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Bought 60,000 shares
@ $1.09, valued at
$65.4k
|
|
03/16/2022 |
4
| Kinder Gordon Winston (CFO) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Bought 10,500 shares
@ $0.95, valued at
$10k
Bought 500 shares
@ $0.91, valued at
$455 Bought 5,000 shares
@ $1.02, valued at
$5.1k
|
|
02/28/2022 |
4
| Dey Indranil (President and CEO) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 14,116 options to buy
@ $1.09, valued at
$15.4k
|
|
02/28/2022 |
4
| Kinder Gordon Winston (CFO) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 8,066 options to buy
@ $1.09, valued at
$8.8k
|
|
01/13/2022 |
4
| ZEIDMAN FRED S (Director) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 15,000 options to buy
@ $2.79, valued at
$41.9k
|
|
01/13/2022 |
4
| Wurth Douglas Clark (10% Owner) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 25,000 options to buy
@ $2.79, valued at
$69.8k
|
|
01/13/2022 |
4
| Dey Svetlana (10% Owner) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 25,000 options to buy
@ $2.79, valued at
$69.8k
|
|
01/13/2022 |
4
| CHASE DONALD R (Director) has filed a Form 4 on Bluejay Diagnostics, Inc.
Txns:
| Granted 25,000 options to buy
@ $2.79, valued at
$69.8k
|
|
12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|